stonkbuilderCOMMUNITY NeuralinkVideosl-UvOz-pw7o
Independent Research Notice: Independent StonkBuilder Community research publication. Not affiliated with, operated by, or endorsed by Neuralink Corp. or PreStocks. Neuralink devices are investigational and have not received FDA marketing authorization. Nothing here is medical, legal, or financial advice. PreStocks tokens are not Neuralink shares, confer no shareholder rights, and are unavailable to U.S. persons and residents of prohibited jurisdictions.

Restoring Speech With Telepathy: technical breakdown, key moments and clinical context

Published on 26 March 2026 ('Restoring Speech With Telepathy', 0:37 Short), this brief pairs commentary on Neuralink's near-term medical objective—reducing human suffering in severe paralysis and ALS—with footage from the VOICE speech restoration trial.

26 Mar 2026Published dateOfficial @neuralink Short · 0:37
l-UvOz-pw7oYouTube Video IDChannel UCLt4d8cACHzrVvAz9gtaARA · Embeddable (200 OK)
Tier 1Evidence classHuman Trial (VOICE)
Speech restorationPrimary topicPaired with /neuralink/speech-restoration
Key points
  • Primary record: Official @neuralink short (l-UvOz-pw7o) published on 26 Mar 2026 (duration 0:37).
  • What it shows: Alignment between the VOICE clinical protocol (NCT07224256) and near-term assistive communication goals.
  • Technical pathway: Speech motor cortex → N1 implant → neural speech decoder → voice output.
  • Evidence boundary: 37-second Short featuring founder commentary alongside VOICE trial footage.

Watch the official video record

Poster illustration for Restoring Speech With Telepathy
Official @neuralink Short 26 Mar 2026 · 0:37 Tier 1 · Human Trial (VOICE)
Restoring Speech With Telepathy

Click to load the privacy-enhanced youtube-nocookie.com player. No third-party cookies or requests are sent until you press play.

Watch on YouTube ↗
Source: Neuralink (@neuralink) · Channel UCLt4d8cACHzrVvAz9gtaARA · Video l-UvOz-pw7o · Checked 30 Oct 2026 Direct YouTube link ↗

Official upload from @neuralink (26 Mar 2026, 0:37).

Read verbatim official @neuralink YouTube description & caption provenance

Caption & verification basis: English manual + auto-generated captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).

Elon Musk shares his vision for Neuralink and one of its primary objectives: reducing human suffering. 

Through the VOICE clinical trial, we are seeing how brain-computer interfaces could help restore speech to those who have lost it due to ALS.

Click here to see the full video: https://youtu.be/u8mmn9lOIyw

Note: Neuralink devices are investigational and are not commercially available or FDA approved. There are no guaranteed benefits from participating in a Neuralink clinical trial.

Technical pathway and evidence classification

Video notes · 26 Mar 2026 · Short (0:37) VOICE Clinical Trial Mission & Architecture Brief
EVIDENCE CLASSIFICATION Tier 1 · Human Trial (VOICE) Video ID: l-UvOz-pw7o Published: 26 Mar 2026 (0:37) PRIMARY SUBSYSTEM Speech restoration (VOICE) Channel: @neuralink (verified) Embed: Embeddable (youtube-nocookie) INTERPRETATION BOUNDARY Investigational Context Not FDA marketing approval Verify against clinical registries
Technical pathway Signal & hardware chain

Speech motor cortex → N1 implant → neural speech decoder → voice output

Analytical scope What to keep in mind

37-second Short featuring founder commentary alongside VOICE trial footage.

Timestamped breakdown and key moments

Sequential moments in Restoring Speech With Telepathy (0:37)
TimestampSegment / eventWhat happens in the segment
00:00Primary medical objectiveFocuses on addressing severe unmet medical needs in ALS and paralysis.
00:18VOICE trial demonstration excerptShows neural speech synthesis in action.

What this video demonstrates—and what it does not establish

What this video demonstrates

  • Alignment between the VOICE clinical protocol (NCT07224256) and near-term assistive communication goals.

Scope limits & what it does not establish

  • 37-second summary clip; refer to `u8mmn9lOIyw` for full participant and engineering details.

How this fits into Neuralink's broader clinical and hardware roadmap

This video sits inside the Speech restoration (VOICE) research track on StonkBuilder's independent Neuralink hub. All Neuralink hardware (the N1 implant and R1 surgical robot) and clinical programs (PRIME NCT06429735, CONVOY, and VOICE NCT07224256) remain investigational and have not received FDA commercial marketing authorization. Read our full companion guide at Speech restoration (VOICE) for cohort context.

Sources checked 30 Oct 2026

Sources and official records

  1. [1] Neuralink YouTube (2026-03-26): Restoring Speech With Telepathy · Verified 30 Oct 2026
  2. [2] Neuralink: Official YouTube Channel (@neuralink, UCLt4d8cACHzrVvAz9gtaARA) · Verified 30 Oct 2026
  3. [3] Neuralink: Official website and investigational device notice · Verified 30 Oct 2026
  4. [4] Neuralink: Speech Restoration (VOICE study overview) · Verified 30 Oct 2026
  5. [5] ClinicalTrials.gov: The VOICE Study for Communication Restoration (NCT07224256) · Verified 30 Oct 2026